227 related articles for article (PubMed ID: 34606125)
1. Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma.
Deng R; Li J; Zhao H; Zou Z; Man J; Cao J; Yang L
J Clin Lab Anal; 2021 Nov; 35(11):e24022. PubMed ID: 34606125
[TBL] [Abstract][Full Text] [Related]
2. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
Luo L; Zhou H; Su H
BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
[TBL] [Abstract][Full Text] [Related]
3. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
6. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
He Z; Sun M; Ke Y; Lin R; Xiao Y; Zhou S; Zhao H; Wang Y; Zhou F; Zhou Y
Oncotarget; 2017 Apr; 8(17):27904-27914. PubMed ID: 28427189
[TBL] [Abstract][Full Text] [Related]
7. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
[TBL] [Abstract][Full Text] [Related]
8. Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.
Liu T; Zhang M; Sun D
Biomed Res Int; 2020; 2020():5019746. PubMed ID: 32775427
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
[TBL] [Abstract][Full Text] [Related]
10. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
[TBL] [Abstract][Full Text] [Related]
11. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
13. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
[TBL] [Abstract][Full Text] [Related]
15. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
16. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
[TBL] [Abstract][Full Text] [Related]
17. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation.
Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S
Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514
[TBL] [Abstract][Full Text] [Related]
18. Gene expression-based immune infiltration analyses of renal cancer and their associations with survival outcome.
Chen L; Yin L; Qi Z; Li J; Wang X; Ma K; Liu X
BMC Cancer; 2021 May; 21(1):595. PubMed ID: 34030645
[TBL] [Abstract][Full Text] [Related]
19. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
20. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
Luo W; Wang L; Luo MH; Huang YZ; Yang H; Zhou Y; Jia HT; Wang XX
J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
